Valrin

Valrin

valsartan

Manufacturer:

Yarindo Farmatama

Marketer:

Yarindo Farmatama
Concise Prescribing Info
Contents
Valsartan
Indications/Uses
HTN, heart failure (NYHA class II-IV) in patients intolerant of ACE inhibitors. Post-MI.
Dosage/Direction for Use
HTN 80 mg once daily, may be increased to 160 mg daily or a diuretic may be added if BP is not adequately controlled. Heart failure Initially 40 mg twice daily. Max: 320 mg daily in divided doses. Post-MI Initially 20 mg twice daily, may be gradually increased to 40 mg, 80 mg, 160 mg twice daily for the further several wk.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Severe liver damage. Liver cirrhosis. Biliary obstruction. Pregnancy.
Special Precautions
May impair ability to drive & operate machinery. Na or vol-depletion, bilateral or unilateral renal artery stenosis, severe kidney dysfunction, liver impairment, heart failure or post-MI. Lactation.
Adverse Reactions
Reduced Hb & hematocrit, neutropenia, thrombocytopenia, hypersensitivity, increased serum K, vertigo, vasculitis, cough, abdominal pain, increased LFT including serum bilirubin, angioedema, rash, pruritus, myalgia, kidney impairment, increased serum creatinine & BUN, fatigue, dizziness, postural dizziness.
Drug Interactions
K-sparing diuretics, NSAIDs.
MIMS Class
Angiotensin II Antagonists
ATC Classification
C09CA03 - valsartan ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Valrin FC tab 160 mg
Packing/Price
3 × 10's
Form
Valrin FC tab 80 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in